Englewood, CO, United States of America

Eunice York


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eunice York: Innovator in Anti-Cancer Compounds

Introduction

Eunice York is a notable inventor based in Englewood, Colorado, recognized for her contributions to the field of anti-cancer research. With a total of two patents to her name, she has made significant strides in developing compounds that inhibit tumor growth and induce apoptosis.

Latest Patents

Her latest patents include innovative anti-cancer compounds and methods related thereto. The present invention provides compounds useful to inhibit tumor growth and to induce apoptosis. In general, the anti-cancer agents (ACA) are described by the formula: [ACA]-X[Formula I], wherein X is a linker group having 2–5 functional groups or is absent, n=1, and ACA is selected from the group consisting of Formula II, Formula III, Formula IV, Formula V, and Formula VI, as described herein. Other compounds described herein are defined by the Formula VII, as described herein.

Career Highlights

Eunice has worked with various organizations, including the University of Colorado, where she has contributed her expertise in cancer research. Her work has been pivotal in advancing the understanding and treatment of cancer through innovative compounds.

Collaborations

Eunice has collaborated with notable individuals in her field, including John M. Stewart and Daniel C. F. Chan. These collaborations have further enhanced her research and development efforts in anti-cancer technologies.

Conclusion

Eunice York's work in developing anti-cancer compounds showcases her dedication to innovation in medical research. Her contributions are vital in the ongoing fight against cancer, and her patents reflect her commitment to improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…